๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anemia in IBD: The overlooked villain

โœ Scribed by Dr. Christoph Gasche


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
873 KB
Volume
6
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

โœฆ Synopsis


During the past decade relevant progress has been made in the understanding and treatment of IBD-associated anemia. Effective replacement of iron deficits has become safe by using novel intravenous iron preparations such as iron sucrose. The ability of erythropoietin to interfere with key mechanisms of myelosuppression in anemia of chronic diseases also benefits patients with IBD-associated anemia. Concerns about cost effectiveness have been raised and weighed against the potential improvement in quality of life. Gastroenterologists who are caring for IBD patients should be concerned with low hemoglobin levels, since the quality of life in these patients can be as low as in anemic patients with advanced cancer. Also provided is a structured approach to cost-effective therapy.


๐Ÿ“œ SIMILAR VOLUMES


Nailing down the shingles in IBD
โœ Camille Nelson Kotton ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 49 KB

A re patients with inflammatory bowel disease (IBD) at increased risk for herpes zoster? Gupta et al used the General Practice Research Database from 1988 -1997, a database of primary care medical records from the United Kingdom representing 6% of the population, to perform a retrospective cohort st

Disability in IBD: The devil is in the d
โœ Joseph Sellin ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 55 KB

## Disability in IBD: The Devil Is in the Details Ask a gastroenterologist ''How many of your patients with IBD are disabled?'' and the answers may vary from <5% to >30%. It is surprising how little is known about disability in patients with IBD. As Peyrin-Biroulet et al 1 point out, there are few